Lists
Lists
Sadeghimakki, Roham and Tahrani, Abd A. (2023) Cardiopulmonary outcomes in people with impaired lung function: the role of metabolic syndrome. The Lancet regional health. Europe, 35 (100796). pp. 1-2. ISSN 2666-7762
Impaired lung function, either with airflow limitation or with preserved ratio impaired spirometry (PRISm), is common globally and associated with increased cardiorespiratory morbidity, cause-specific mortality and overall mortality.1,2 In this context, understanding the impact of metabolic syndrome on cardiopulmonary outcomes is clinically important, given the growing global prevalence of metabolic syndrome, driven in part by the increasing obesity rates, and its associations with major adverse cardiovascular events and all-cause mortality.
Available under License Creative Commons Attribution Non-commercial No Derivatives 4.0.
Download (155kB) | Preview
 |
View Item |